Predictors of sustained intraocular pressure elevation in eyes receiving intravitreal anti-vascular endothelial growth factor therapy

American Journal of Ophthalmology

Volumn 158, Issue 2, 2014, Pages

  Yannuzzi, Nicolas A ^a,b   Patel, Samir N ^a,b   Bhavsar, Kavita V ^b,c,d,e   Sugiguchi, Fumitaka ^a,b   Freund, K Bailey ^b,c,d,e  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b EAR AND THROAT HOSPITAL   (United States)

^c VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLIBERCEPT; BEVACIZUMAB; RANIBIZUMAB;

ANTERIOR EYE CHAMBER; ARTICLE; HEALTH SURVEY; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; LENS GAUGE; MEDICAL SPECIALIST; NEEDLE; PARACENTESIS; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CLINICAL COMPETENCE; CROSS-SECTIONAL STUDIES; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; OCULAR HYPERTENSION; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; RISK FACTORS; UNITED STATES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84905089653     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2014.04.029     Document Type: Article

References (27)

1. J.J. Tseng, S.K. Vance, and K.E. Della Torre et al. Sustained increased intraocular pressure related to intravitreal antivascular endothelial growth factor therapy for neovascular age-related macular degeneration J Glaucoma 21 4 2012 241 247
2. T.J. Good, A.E. Kimura, N. Mandava, and M.Y. Kahook Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents Br J Ophthalmol 95 8 2011 1111 1114
3. R.A. Adelman, Q. Zheng, and H.R. Mayer Persistent ocular hypertension following intravitreal bevacizumab and ranibizumab injections J Ocul Pharmacol Ther 26 1 2010 105 110
4. D.Y. Choi, M.C. Ortube, and C.A. McCannel et al. Sustained elevated intraocular pressures after intravitreal injection of bevacizumab, ranibizumab, and pegaptanib Retina 31 6 2011 1028 1035
5. Q.V. Hoang, A.J. Tsuang, and R. Gelman et al. Clinical predictors of sustained intraocular pressure elevation due to intravitreal anti-vascular endothelial growth factor therapy Retina 33 1 2013 179 187
6. N. Mathalone, A. Arodi-Golan, and S. Sar et al. Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration Graefes Arch Clin Exp Ophthalmol 250 10 2012 1435 1440
7. H. Hollands, J. Wong, R. Bruen, R.J. Campbell, S. Sharma, and J. Gale Short-term intraocular pressure changes after intravitreal injection of bevacizumab Can J Ophthalmol 42 6 2007 807 811
8. G. Mojica, S.M. Hariprasad, R.D. Jager, and W.F. Mieler Short-term intraocular pressure trends following intravitreal injections of ranibizumab (Lucentis) for the treatment of wet age-related macular degeneration Br J Ophthalmol 92 4 2008 584
9. S.J. Bakri, J.S. Pulido, C.A. McCannel, D.O. Hodge, N. Diehl, and J. Hillemeier Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab Eye (Lond) 23 1 2009 181 185
10. G. Abedi, R.A. Adelman, and S. Salim Incidence and management of elevated intraocular pressure with antivascular endothelial growth factor agents Semin Ophthalmol 28 3 2013 126 130
11. Q.V. Hoang, L.S. Mendonca, K.E. Della Torre, J.J. Jung, A.J. Tsuang, and K.B. Freund Effect on intraocular pressure in patients receiving unilateral intravitreal anti-vascular endothelial growth factor injections Ophthalmology 119 2 2012 321 326
12. S.J. Wehrli, K. Tawse, M.H. Levin, A. Zaidi, M. Pistilli, and A.J. Brucker A lack of delayed intraocular pressure elevation in patients treated with intravitreal injection of bevacizumab and ranibizumab Retina 32 7 2012 1295 1301
13. F. Höhn, and A. Mirshahi Impact of injection techniques on intraocular pressure (IOP) increase after intravitreal ranibizumab application Graefes Arch Clin Exp Ophthalmol 248 10 2010 1371 1375
14. J.S. Pulido, M.E. Zobitz, and K.N. An Scleral penetration force requirements for commonly used intravitreal needles Eye (Lond) 21 9 2007 1210 1211
15. J.S. Pulido, C.M. Pulido, S.J. Bakri, C.A. McCannel, and J.D. Cameron The use of 31-gauge needles and syringes for intraocular injections Eye (Lond) 21 6 2007 829 830
16. J.E. Kim, A.V. Mantravadi, E.Y. Hur, and D.J. Covert Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents Am J Ophthalmol 146 6 2008 930 934
17. E.B. Rodrigues, A. Grumann Jr., and F.M. Penha et al. Effect of needle type and injection technique on pain level and vitreal reflux in intravitreal injection J Ocul Pharmacol Ther 27 2 2011 197 203
18. L.P. Aiello, A.J. Brucker, and S. Chang et al. Evolving guidelines for intravitreous injections Retina 24 5 Suppl 2004 S3 19
19. M.C. Dwinger, I. Pieper-Bodeewes, N. Eter, and F.G. Holz Variations in intraocular pressure (IOP) and necessity for paracentesis following intravitreal triamcinolone injection Klin Monbl Augenheilkd 222 8 2005 638 642
20. Gregori NZ, Weiss MJ, Goldhardt R, et al. Ocular Decompression With Cotton Swabs Lowers Intraocular Pressure Elevation After Intravitreal Injection. J Glaucoma. (forthcoming).
21. N. Morlet, and S.H. Young Prevention of intraocular pressure rise following intravitreal injection Br J Ophthalmol 77 9 1993 572 573
22. G.N. Kim, Y.S. Han, I.Y. Chung, S.W. Seo, J.M. Park, and J.M. Yoo Effect of Dorzolamide/Timolol or Brinzolamide/Timolol prophylaxis on intravitreal anti-VEGF injection-induced intraocular hypertension Semin Ophthalmol 28 2 2013 61 67
23. L. Liu, D.A. Ammar, L.A. Ross, N. Mandava, M.Y. Kahook, and J.F. Carpenter Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling Invest Ophthalmol Vis Sci 52 2 2011 1023 1034
24. M. Sniegowski, N. Mandava, and M.Y. Kahook Sustained intraocular pressure elevation after intravitreal injection of bevacizumab and ranibizumab associated with trabeculitis Open Ophthalmol J 4 2010 28 29
25. M.Y. Kahook, L. Liu, and P. Ruzycki et al. High-molecular-weight aggregates in repackaged bevacizumab Retina 30 6 2010 887 892
26. M.Y. Kahook, and D.A. Ammar In vitro effects of antivascular endothelial growth factors on cultured human trabecular meshwork cells J Glaucoma 19 7 2010 437 441
27. Q.V. Hoang, J.J. Jung, S. Mrejen, and K.B. Freund Influence of axial length and postinjection reflux on sustained intraocular pressure elevation as a result of intravitreal anti-vascular endothelial growth factor therapy Retina 34 3 2014 519 524